| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |